TGFbeta-SMAD2/3 signaling inhibits IRF2 to drive metastasis in KRAS-mutant colorectal Cancer. Shu F, Zhang T, Chen X, Lu G, et al. Cancer Lett 2026 Apr 14:218507. doi: 10.1016/j.canlet.2026.218507.

Read + Share

Amedeo Smart

Independent Medical Education

Shu F, Zhang T, Chen X, Lu G, et al. TGFbeta-SMAD2/3 signaling inhibits IRF2 to drive metastasis in KRAS-mutant colorectal Cancer. Cancer Lett 2026 Apr 14:218507. doi: 10.1016/j.canlet.2026.218507.
PMID: 41985874